Let’s Talk… HCC at EASL Liver Cancer Summit 2023

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Apr 22 / Springer Healthcare

Let’s Talk… HCC at EASL Liver Cancer Summit 2023

Oncology Hepatocellular Carcinoma EASL-LIVER-CANCER-SUMMIT-2023

Description

In this episode, Nathalie Ganne-Carrié and María Reig review the systemic treatment presentations at the Liver Cancer Summit for advanced hepatocellular carcinoma and the optimal management of immunotherapy-related adverse events.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.